CyGenics Ltd Limited Expands With 20% Stake In PharmaCell BV Cell Therapy

CyGenics Ltd. (ASX: CYN) today formally completed its strategic investment of an initial 20% stake in Dutch-based Pharmacell BV, with an option to purchase the remaining 80% at a later date.

MORE ON THIS TOPIC